These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24430886)

  • 21. The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?
    van Kampen J; Stoessl AJ
    Neuropharmacology; 1997; 36(11-12):1679-88. PubMed ID: 9517439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.
    Luckman SM; Hamamura M; Antonijevic I; Dye S; Leng G
    Br J Pharmacol; 1993 Sep; 110(1):378-84. PubMed ID: 8220899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining the role of cholecystokinin in appetitive learning in the infant rat.
    Weller A; Tsitolovskya L; Gispan IH; Rabinovitz S
    Peptides; 2001 Aug; 22(8):1317-23. PubMed ID: 11457527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actions of adiponectin on the excitability of subfornical organ neurons are altered by food deprivation.
    Alim I; Fry WM; Walsh MH; Ferguson AV
    Brain Res; 2010 May; 1330():72-82. PubMed ID: 20206611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both afferent and efferent nerves are implicated in cholecytokinin motor actions in the small intestine of the rat.
    Giralt M; Vergara P
    Regul Pept; 1999 May; 81(1-3):73-80. PubMed ID: 10395411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms for the growth factor action of gastrin.
    Todisco A; Takeuchi Y; Urumov A; Yamada J; Stepan VM; Yamada T
    Am J Physiol; 1997 Oct; 273(4):G891-8. PubMed ID: 9357832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of the gastric vagal afferent activity to cholecystokinin in rats lacking type A cholecystokinin receptors.
    Kurosawa M; Bucinskaite V; Taniguchi T; Miyasaka K; Funakoshi A; Lundeberg T
    J Auton Nerv Syst; 1999 Jan; 75(1):51-9. PubMed ID: 9935269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of CCK in the paraventricular nucleus of the hypothalamus in the CNS regulation of colonic motility.
    Mönnikes H; Tebbe J; Grote C; Sonntag A; Pluntke K; Sturm K; Arnold R
    Digestion; 2000; 62(2-3):178-84. PubMed ID: 11025366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of peripheral CCK receptor blockade on gastric emptying in rats.
    Reidelberger RD; Kelsey L; Heimann D; Hulce M
    Am J Physiol Regul Integr Comp Physiol; 2003 Jan; 284(1):R66-75. PubMed ID: 12388446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors.
    Legido A; Adler MW; Karkanias C; Geller EB; Bradley E; Greenstein JI; Grover WD
    Neuropeptides; 1995 Feb; 28(2):107-13. PubMed ID: 7746354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proinflammatory cytokine tumor necrosis factor-α excites subfornical organ neurons.
    Simpson NJ; Ferguson AV
    J Neurophysiol; 2017 Sep; 118(3):1532-1541. PubMed ID: 28637815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-analgesia and reduced antinociception from supraspinally administered beta-endorphin in stressed rats: dependence on spinal cholecystokinin via cholecystokinin B receptors.
    Hawranko AA; Serafini M; Smith DJ
    Neurosci Lett; 1999 May; 267(2):101-4. PubMed ID: 10400222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin-8 (CCK-8) has no effect on heart rate in rats lacking CCK-A receptors.
    Kurosawa M; Iijima S; Funakoshi A; Kawanami T; Miyasaka K; Bucinskaite V; Lundeberg T
    Peptides; 2001 Aug; 22(8):1279-84. PubMed ID: 11457521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.